Can we predict psychosis outside the clinical high-risk state? A systematic review of non-psychotic risk syndromes for mental disorders

Schizophrenia Bulletin

Volumn 44, Issue 2, 2018, Pages 276-285

  Lee, Tae Young ^a   Lee, Junhee ^a   Kim, Minah ^a   Choe, Eugenie ^a   Kwon, Jun Soo ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIPOLAR DISORDER; BIPOLAR I DISORDER; COCHRANE LIBRARY; EMBASE; GENERALIZED ANXIETY DISORDER; HUMAN; MEDLINE; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SYSTEMATIC REVIEW; DEPRESSION; PANIC; PRODROMAL SYMPTOM; RISK ASSESSMENT; STANDARDS; STATISTICS AND NUMERICAL DATA;

BIPOLAR DISORDER; DEPRESSIVE DISORDER; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PANIC DISORDER; PRODROMAL SYMPTOMS; PSYCHOTIC DISORDERS; RISK ASSESSMENT;

EID: 85045941434     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbx173     Document Type: Review

References (67)

1. Fava GA, Kellner R. Prodromal symptoms in affective disorders. Am J Psychiatry. 1991;148:823-830.
2. Fusar-Poli P. The Clinical High-Risk State for Psychosis (CHR-P), Version II. Schizophr Bull. 2017;43:44-47.
3. Geoffroy PA, Scott J. Prodrome or risk syndrome: what's in a name? Int J Bipolar Disord. 2017;5:7.
4. Fusar-Poli P, Cappucciati M, Borgwardt S, et al. Heterogeneity of psychosis risk within individuals at clinical high risk: a meta-analytical stratification. JAMA Psychiatry. 2016;73:113-120.
5. Fusar-Poli P, Palombini E, Davies C, et al. Why transition risk to psychosis is not declining at the OASIS ultra high risk service: The hidden role of stable pretest risk enrichment. Schizophr Res. 2017. doi:10.1016/j.schres.2017.06.015.
6. Yung AR, Yuen HP, Berger G, et al. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull. 2007;33:673-681.
7. Fusar-Poli P, Bonoldi I, Yung AR, et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry. 2012;69:220-229.
8. Addington J, Cornblatt BA, Cadenhead KS, et al. At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry. 2011;168:800-805.
9. Lee TY, Kim SN, Correll CU, et al. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study. Schizophr Res. 2014;156:266-271.
10. Lim KO, Lee TY, Kim M, Chon MW, Yun JY, Kim SN, Kwon JS. Early referral and comorbidity as possible causes of the declining transition rate in subjects at clinical high risk for psychosis. Early Interv Psychiatry. 2016. http://onlinelibrary.wiley.com/doi/10.1111/eip.12363/abstract;jsessionid=ABAB D8210FC3ABC14CCE5B5E0C318D16.f04t04
11. Nelson B, Yuen HP, Lin A, et al. Further examination of the reducing transition rate in ultra high risk for psychosis samples: the possible role of earlier intervention. Schizophr Res. 2016;174:43-49.
12. Fusar-Poli P, Schultze-Lutter F, Cappucciati M, et al. The dark side of the moon: meta-analytical impact of recruitment strategies on risk enrichment in the clinical high risk state for psychosis. Schizophr Bull. 2016;42:732-743.
13. Fusar-Poli P. Why ultra high risk criteria for psychosis prediction do not work well outside clinical samples and what to do about it. World Psychiatry. 2017;16:212-213.
14. Fusar-Poli P, Schultze-Lutter F. Predicting the onset of psychosis in patients at clinical high risk: practical guide to probabilistic prognostic reasoning. Evid Based Ment Health. 2016;19:10-15.
15. Webb JR, Addington J, Perkins DO, et al. Specificity of incident diagnostic outcomes in patients at clinical high risk for psychosis. Schizophr Bull. 2015;41:1066-1075.
16. Fusar-Poli P, Rutigliano G, Stahl D, et al. Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders. Eur Psychiatry. 2017;42:49-54.
17. Rosen JL, Miller TJ, D'Andrea JT, McGlashan TH, Woods SW. Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome. Schizophr Res. 2006;85:124-131.
18. Correll CU, Penzner JB, Frederickson AM, et al. Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome. Schizophr Bull. 2007;33:703-714.
19. Niendam TA, Berzak J, Cannon TD, Bearden CE. Obsessive compulsive symptoms in the psychosis prodrome: correlates of clinical and functional outcome. Schizophr Res. 2009;108:170-175.
20. Akiskal HS, Bitar AH, Puzantian VR, Rosenthal TL, Walker PW. The nosological status of neurotic depression: a prospective three- to four-year follow-up examination in light of the primary-secondary and unipolar-bipolar dichotomies. Arch Gen Psychiatry. 1978;35:756-766.
21. Fusar-Poli P, Cappucciati M, Rutigliano G, et al. At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction. World Psychiatry. 2015;14:322-332.
22. Fusar-Poli P, De Micheli A, Cappucciati M, et al. Diagnostic and Prognostic Significance of DSM-5 Attenuated Psychosis Syndrome in Services for Individuals at Ultra High Risk for Psychosis. Schizophr Bull. 2018;44:264-275
23. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
24. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
25. Weiser M, Lubin G, Caspi A, et al. Dysthymia in male adolescents is associated with increased risk of later hospitalization for psychotic disorders: a historical-prospective cohort study. Early Interv Psychiatry. 2008;2:67-72.
26. Van Dael F, van Os J, de Graaf R, ten Have M, Krabbendam L, Myin-Germeys I. Can obsessions drive you mad? Longitudinal evidence that obsessive-compulsive symptoms worsen the outcome of early psychotic experiences. Acta Psychiatr Scand. 2011;123:136-146.
27. Conus P, Ward J, Lucas N, et al. Characterisation of the prodrome to a first episode of psychotic mania: results of a retrospective study. J Affect Disord. 2010;124:341-345.
28. Bechdolf A, Nelson B, Cotton SM, et al. A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults. J Affect Disord. 2010;127:316-320.
29. Correll CU, Olvet DM, Auther AM, et al. The Bipolar Prodrome Symptom Interview and Scale-Prospective (BPSS-P): description and validation in a psychiatric sample and healthy controls. Bipolar Disord. 2014;16:505-522.
30. Jablensky A. Epidemiology of schizophrenia: the global burden of disease and disability. Eur Arch Psychiatry Clin Neurosci. 2000;250:274-285.
31. Kirkbride JB, Errazuriz A, Croudace TJ, et al. Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One 2012;7:e31660.
32. Sutterland AL, Dieleman J, Storosum JG, et al. Annual incidence rate of schizophrenia and schizophrenia spectrum disorders in a longitudinal population-based cohort study. Soc Psychiatry Psychiatr Epidemiol. 2013;48:1357-1365.
33. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med. 2004;2:13.
34. Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry. 2001;58:158-164.
35. Yung AR, Nelson B, Stanford C, et al. Validation of “prodromal” criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res. 2008;105:10-17.
36. Riecher-Rössler A, Aston J, Ventura J, et al. The Basel Screening Instrument for Psychosis (BSIP): development, structure, reliability and validity. Fortschr Neurol Psychiatr. 2008;76:207-216.
37. Woods SW, Addington J, Cadenhead KS, et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull. 2009;35:894-908.
38. Addington J, Piskulic D, Perkins D, Woods SW, Liu L, Penn DL. Affect recognition in people at clinical high risk of psychosis. Schizophr Res. 2012;140:87-92.
39. Liu CC, Lai MC, Liu CM, et al. Follow-up of subjects with suspected pre-psychotic state in Taiwan. Schizophr Res. 2011;126:65-70.
40. Simon AE, Grädel M, Cattapan-Ludewig K, et al. Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome. Schizophr Res. 2012;142:108-115.
41. Lee J, Rekhi G, Mitter N, et al. The Longitudinal Youth at Risk Study (LYRIKS)-an Asian UHR perspective. Schizophr Res. 2013;151:279-283.
42. Spada G, Molteni S, Pistone C, et al. Identifying children and adolescents at ultra high risk of psychosis in Italian neuro-psychiatry services: a feasibility study. Eur Child Adolesc Psychiatry. 2016;25:91-106.
43. Schultze-Lutter F, Klosterkötter J, Ruhrmann S. Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms. Schizophr Res. 2014;154:100-106.
44. Kotlicka-Antczak M, Pawełczyk T, Rabe-Jabłońska J, Pawełczyk A. PORT (Programme of Recognition and Therapy): the first Polish recognition and treatment pro-gramme for patients with an at-risk mental state. Early Interv Psychiatry. 2015;9:339-342.
45. Johannessen JO, McGorry P. DSM-5 and the 'Psychosis Risk Syndrome': the need for a broader perspective. Psychosis. 2010;2:93-96.
46. Woods S, Powers A, Taylor J, et al. Lack of diagnostic pluripotentiality in patients at clinical high risk for psychosis: specificity of comorbidity persistence and search for pluripotential subgroups. Schizophr Bull. 2018;44:254-263.
47. Fusar-Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull. 2014;40:120-131.
48. Michel C, Ruhrmann S, Schimmelmann BG, Klosterkotter J, Schultze-Lutter F. Course of clinical high-risk states for psychosis beyond conversion. Eur Arch Psychiatry Clin Neurosci. 2017. https://link.springer.com/article/10.1007/ s00406-016-0764-8
49. Lin A, Wood SJ, Nelson B, Beavan A, McGorry P, Yung AR. Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis. Am J Psychiatry. 2015;172:249-258.
50. Woods SW, Walsh BC, Addington J, et al. Current status specifiers for patients at clinical high risk for psychosis. Schizophr Res. 2014;158:69-75.
51. Fusar-Poli P, Borgwardt S. Predictive power of attenuated psychosis syndrome: is it really low? The case of mild cognitive impairment. Schizophr Res. 2012;135:192-193.
52. Agius M, Zaman R, Hanafy D. An audit to assess the consequences of the use of a pluripotential risk syndrome: the case to move on from “psychosis risk syndrome (PRS)”. Psychiatr Danub. 2013;25(suppl 2):S282-S285.
53. Mishara AL, Fusar-Poli P. The phenomenology and neurobiology of delusion formation during psychosis onset: Jaspers, Truman symptoms, and aberrant salience. Schizophr Bull. 2013;39:278-286.
54. Alloy LB, Urošević S, Abramson LY, et al. Progression along the bipolar spectrum: a longitudinal study of predictors of conversion from bipolar spectrum conditions to bipolar I and II disorders. J Abnorm Psychol. 2012;121:16-27.
55. Kessing LV. Diagnostic stability in bipolar disorder in clinical practise as according to ICD-10. J Affect Disord. 2005;85:293-299.
56. Fusar-Poli P, Rutigliano G, Stahl D, et al. Development and validation of a clinically based risk calculator for the transdiagnostic prediction of psychosis. JAMA Psychiatry. 2017;74:493-500.
57. Bechdolf A, Ratheesh A, Cotton SM, et al. The predictive validity of bipolar at-risk (prodromal) criteria in help-seeking adolescents and young adults: a prospective study. Bipolar Disord. 2014;16:493-504.
58. Leopold K, Ritter P, Correll CU, et al. Risk constellations prior to the development of bipolar disorders: rationale of a newriskassessmenttool.JAffectDisord.2012;136:1000-1010.
59. Duffy A. The early natural history of bipolar disorder: what we have learned from longitudinal high-risk research. Can J Psychiatry. 2010;55:477-485.
60. Correll CU, Hauser M, Penzner JB, et al. Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episode. Bipolar Disord. 2014;16:478-492.
61. Correll CU, Penzner JB, Lencz T, et al. Early identification and high-risk strategies for bipolar disorder. Bipolar Disord. 2007;9:324-338.
62. Kim EY, Miklowitz DJ. Childhood mania, attention deficit hyperactivity disorder and conduct disorder: a critical review of diagnostic dilemmas. Bipolar Disord. 2002;4:215-225.
63. Fusar-Poli P, Cappucciati M, Rutigliano G, et al. Towards a standard psychometric diagnostic interview for subjects at ultra high risk of psychosis: CAARMS versus SIPS. Psychiatry J. 2016;2016:7146341.
64. Fusar-Poli P. Extending the benefits of indicated prevention to improve outcomes of first-episode psychosis. JAMA Psychiatry. 2017;74:667-668.
65. Faedda GL, Baldessarini RJ, Glovinsky IP, Austin NB. Pediatric bipolar disorder: phenomenology and course of illness. Bipolar Disord. 2004;6:305-313.
66. Faravelli C, Rosi S, Alessandra Scarpato M, Lampronti L, Amedei SG, Rana N. Threshold and subthreshold bipolar disorders in the Sesto Fiorentino Study. J Affect Disord. 2006;94:111-119.
67. Goodwin RD, Hamilton SP. The early-onset fearful panic attack as a predictor of severe psychopathology. Psychiatry Res. 2002;109:71-79.